(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-8b-acetyl-7-hydroxy-6a,8a,10-trimethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d]oxazol-4(2H)-one; (11?,16?)-11-hydroxy-2'-methyl-5'H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione; (11?,16?)-11?-hydroxy-2'-methyl-5?H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione; 11?-hydroxy-2'-methyl-5'?H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione; Desacetoxy Deflazacort
21-Deacetoxy Deflazacort is a fully characterized chemical compound used as a reference standard of API Deflazacort. The standard offered is compliant with regulatory guidelines. 21-Deacetoxy Deflazacort is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 13649-88-2
